Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-28 Purchase |
2024-04-01 4:15 pm |
Alto Neuroscience Inc. | ANRO | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER |
6,150 | $16.36 | $100,628 | 26,866 (Direct) |
View |
| 2024-02-06 Purchase |
2024-02-07 4:40 pm |
Alto Neuroscience Inc. | ANRO | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER |
1,563 | $16 | $25,008 | 1,563 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-05 Option Award |
2025-02-07 4:22 pm |
N/A 2035-02-04 |
Alto Neuroscience Inc. | ANRO | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO |
135,000 | $0 | 135,000 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 6:00 pm |
N/A 2034-02-28 |
Alto Neuroscience Inc. | ANRO | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER |
109,153 | $0 | 110,716 (Direct) |
View |
Ownership |
2024-02-01 6:48 pm |
N/A 2031-09-08 |
Alto Neuroscience Inc. | ANRO | Smith Nicholas Conrad Chief Financial Officer |
0 | $0 | 416,010 (Direct) |
View |